44 results
424B3
ATXI
Avenue Therapeutics Inc
28 Jun 23
Prospectus supplement
4:56pm
, (which AnnJi is administering with Joint Steering Committee Oversight before assigning the Investigational New Drug to the Company upon such trial’s
8-K
EX-1.1
gam 0t3htkh4np7a
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
424B4
npylbhlwzc b6lm
11 Oct 22
Prospectus supplement with pricing info
8:27am
8-K
EX-1.1
qj2yofo fce7
13 Dec 21
Entry into a Material Definitive Agreement
9:23am